Associate Professor, McGill University
Attending Physician, Department of Medicine, Division of Infectious Diseases and Research Scientist, Centre for Clinical Epidemiology and Community Studies, Jewish General Hospital
Staff Physician, JD Maclean Tropical Medicine Centre, McGill University
Associate Member Department of Epidemiology and Biostatistics, McGill University
Dr. Chris Greenaway is an attending physician in the Divisions of Infectious Diseases and Laboratory Medicine at the Jewish General Hospital, staff physician at the JD Maclean Tropical Medicine Centre at McGill, a Research Scientist at the Centre for Clinical Epidemiology and Community Studies at the Jewish General Hospital, and Associate Member of the Department of Epidemiology and Biostatistics at McGill University. Her research is focused on health issues related to immigrants and refugees, measuring the burden of infectious diseases in this population, and designing interventions to decrease their burden. Since 2007, she has been a Steering Committee Member for the Canadian Collaboration on Immigrant and Refugee Health (CCIRH), a national collaboration that includes specialists, primary care practitioners, researchers, policy makers, and immigrant community leaders dedicated to improving the health of immigrants and refugees. They have developed, and recently published in the Canadian Medical Association Journal, "Evidence Based Clinical Care Guidelines for Immigrants and Refugees." Dr. Greenaway was the first author on sections of the guidelines pertaining to tuberculosis, hepatitis B, hepatitis C, childhood vaccine preventable diseases, and varicella, and a co-author on the section on intestinal parasites. She is supported by a Career Award (Clinician-Scientist Junior 2) from the Fond de la research en santé de Quebec (FRSQ).
Major Research Activities
Her major research focus has been on measuring the incidence/prevalence, and associated morbidity and mortality, of infectious diseases in immigrants and refugees after arrival, and designing targeted interventions to decrease this burden. Since coming to the JGH in 2011, she has undertaken observational studies (cross-sectional and large linked cohort studies) to determine the susceptibility to childhood vaccine preventable diseases including varicella, and the rates of morbidity and mortality due to viral hepatitis, tuberculosis, and intestinal parasites in the immigrant population. She is conducting several systematic reviews and meta-analyses on the burden of different infectious disease in the immigrant population and the effectiveness of immigrant tuberculosis screening programs. She has also published a cost-effectiveness analysis to determine the optimal vaccination strategy to decrease the burden varicella has on the immigrant population, and is conducting another on measles, mumps, and rubella (MMR). She has been involved, with the CCIRH, in developing evidence-based clinical care guidelines for newly arrived immigrants that are targeted at primary care practitioners with an objective of improving the health of the immigrant population. She will be involved in an extensive knowledge translation plan for dissemination of these guidelines.
Recent Publications
Pottie K, Greenaway C, Feightner J, Welch V, Swinkels H, Rashid M, Narasiah L, Kirmayer L, Ueffing E, MacDonald N, Hassan G, McNally C, Kahn K, Burhmann R, Dunn S, Dominic A, McCarthy AE, Gagnon A, Rousseau C, Tugwell P and the Canadian Collaboration for Immigrant and Refugee Health. Review: Evidence-based clinical guidelines for immigrants and refugees. Can Med Assoc. J. Epub 2011 July 15. DOI: 10.1503/cmaj.090313. E1-E7.
Greenaway C, Boivin JF, Dongier P, Taperio B, Miller M, Schwartzman K. Susceptibility to Measles, Mumps, Rubella in Newly Arrived Adult Immigrants and Refugees in Montreal, Canada”. Annals of Internal Medicine. 2007;146:20-24.
Merrett P*, Schwartzman K, Rivest P, Greenaway C. Cost-Effectiveness of Various Varicella Vaccination Strategies in Preventing Varicella in New Immigrants. Clinical Infectious Diseases. 2007; 44:1040-8.